Accès gratuit
Numéro
Med Sci (Paris)
Volume 34, Numéro 5, Mai 2018
Page(s) 417 - 423
Section M/S Revues
DOI https://doi.org/10.1051/medsci/20183405014
Publié en ligne 13 juin 2018
  1. Scherer PE, Williams S, Fogliano M, et al. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995 ; 270 : 26746–26749. [CrossRef] [PubMed] [Google Scholar]
  2. Maeda K, Okubo K, Shimomura I, et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adiPose most abundant gene transcript 1). Biochem Biophys Res Commun 1996 ; 221 : 286–289. [Google Scholar]
  3. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996 ; 271 : 10697–10703. [CrossRef] [PubMed] [Google Scholar]
  4. Nakano Y, Tobe T, Choi-Miura NH, et al. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem 1996 ; 120 : 803–812. [CrossRef] [PubMed] [Google Scholar]
  5. Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 2002 ; 13 : 84–89. [CrossRef] [PubMed] [Google Scholar]
  6. Waki H, Yamauchi T, Kamon J, et al. Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic cell line THP-1. Endocrinology 2005 ; 146 : 790–796. [CrossRef] [PubMed] [Google Scholar]
  7. Qi Y, Takahashi N, Hileman SM, et al. Adiponectin acts in the brain to decrease body weight. Nat Med 2004 ; 10 : 524–529. [CrossRef] [PubMed] [Google Scholar]
  8. Kubota N, Yano W, Kubota T, et al. Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab 2007 ; 6 : 55–68. [CrossRef] [PubMed] [Google Scholar]
  9. Liu J, Guo M, Zhang D, et al. Adiponectin is critical in determining susceptibility to depressive behaviors and has antidepressant-like activity. Proc Natl Acad Sci USA 2012 ; 109 : 12248–12253. [CrossRef] [Google Scholar]
  10. Yau SY, Li A, Hoo RL, et al. Physical exercise-induced hippocampal neurogenesis and antidepressant effects are mediated by the adipocyte hormone adiponectin. Proc Natl Acad Sci USA 2014 ; 111 : 15810–15815. [CrossRef] [Google Scholar]
  11. Chabry J, Nicolas S, Cazareth J, et al. Enriched environment decreases microglia and brain macrophages inflammatory phenotypes through adiponectin-dependent mechanisms: relevance to depressive-like behavior. Brain Behav Immun 2015 ; 50 : 275–287. [CrossRef] [PubMed] [Google Scholar]
  12. Maddineni S, Metzger S, Ocon O, et al. Adiponectin gene is expressed in multiple tissues in the chicken: food deprivation influences adiponectin messenger ribonucleic acid expression. Endocrinology 2005 ; 146 : 4250–4256. [CrossRef] [PubMed] [Google Scholar]
  13. Hoyda TD, Fry M, Ahima RS, Ferguson AV. Adiponectin selectively inhibits oxytocin neurons of the paraventricular nucleus of the hypothalamus. J Physiol 2007 ; 585 : 805–816. [CrossRef] [PubMed] [Google Scholar]
  14. Rodriguez-Pacheco F, Martinez-Fuentes AJ, Tovar S, et al. Regulation of pituitary cell function by adiponectin. Endocrinology 2007 ; 148 : 401–410. [CrossRef] [PubMed] [Google Scholar]
  15. Wilkinson M, Brown R, Imran SA, Ur E. Adipokine gene expression in brain and pituitary gland. Neuroendocrinology 2007 ; 86 : 191–209. [Google Scholar]
  16. Yamauchi T, Kamon J, Ito Y, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003 ; 423 : 762–769. [CrossRef] [PubMed] [Google Scholar]
  17. Suyama S, Lei W, Kubota N, et al. Adiponectin at physiological level glucose-independently enhances inhibitory postsynaptic current onto NPY neurons in the hypothalamic arcuate nucleus. Neuropeptides 2017 ; 65 : 1–9. [CrossRef] [PubMed] [Google Scholar]
  18. Wan Z, Mah D, Simtchouk S, et al. Globular adiponectin induces a pro-inflammatory response in human astrocytic cells. Biochem Biophys Res Commun 2014 ; 446 : 37–42. [Google Scholar]
  19. Nicolas S, Cazareth J, Zarif H, et al. Globular adiponectin limits microglia pro-inflammatory phenotype through an AdipoR1/NF-kappaB signaling pathway. Front Cell Neurosci 2017 ; 11 : 352. [PubMed] [Google Scholar]
  20. Capuron L, Lasselin J, Castanon N. Role of adiposity-driven inflammation in depressive morbidity. Neuropsychopharmacology 2017 ; 42 : 115–128. [CrossRef] [PubMed] [Google Scholar]
  21. Lojko D, Buzuk G, Owecki M, et al. Atypical features in depression: association with obesity and bipolar disorder. J Affect Disord 2015 ; 185 : 76–80. [CrossRef] [PubMed] [Google Scholar]
  22. Jow GM, Yang TT, Chen CL. Leptin and cholesterol levels are low in major depressive disorder, but high in schizophrenia. J Affect Disord 2006 ; 90 : 21–27. [CrossRef] [PubMed] [Google Scholar]
  23. Cizza G, Nguyen VT, Eskandari F, et al. Low 24-hour adiponectin and high nocturnal leptin concentrations in a case-control study of community-dwelling premenopausal women with major depressive disorder: the premenopausal, osteopenia/osteoporosis, women, alendronate, depression (Power) study. J Clin Psychiatry 2010 ; 71 : 1079–1087. [CrossRef] [PubMed] [Google Scholar]
  24. Carvalho AF, Rocha DQ, McIntyre RS, et al. Adipokines as emerging depression biomarkers: a systematic review and meta-analysis. J Psychiatr Res 2014 ; 59 : 28–37. [Google Scholar]
  25. Mansur RB, Rizzo LB, Santos CM, et al. Adipokines, metabolic dysfunction and illness course in bipolar disorder. J Psychiatr Res 2016 ; 74 : 63–69. [Google Scholar]
  26. Zhang D, Wang X, Wang B, et al. Adiponectin regulates contextual fear extinction and intrinsic excitability of dentate gyrus granule neurons through AdipoR2 receptors. Mol Psychiatry 2017 ; 22 : 1044–1055. [CrossRef] [PubMed] [Google Scholar]
  27. Na KS, Kim EK, Park JT. Decreased plasma adiponectin among male firefighters with symptoms of post-traumatic stress disorder. J Affect Disord 2017 ; 221 : 254–258. [CrossRef] [PubMed] [Google Scholar]
  28. Nicolas S, Veyssiere J, Gandin C, et al. Neurogenesis-independent antidepressant-like effects of enriched environment is dependent on adiponectin. Psychoneuroendocrinology 2015 ; 57 : 72–83. [CrossRef] [PubMed] [Google Scholar]
  29. Maeda N, Shimomura I, Kishida K, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 2002 ; 8 : 731–737. [CrossRef] [PubMed] [Google Scholar]
  30. Rovin BH, Song H, Hebert LA, et al. Plasma, urine, and renal expression of adiponectin in human systemic lupus erythematosus. Kidney Int 2005 ; 68 : 1825–1833. [CrossRef] [PubMed] [Google Scholar]
  31. Moriconi N, Kraenzlin M, Muller B, et al. Body composition and adiponectin serum concentrations in adult patients with cystic fibrosis. J Clin Endocrinol Metab 2006 ; 91 : 1586–1590. [CrossRef] [PubMed] [Google Scholar]
  32. Karmiris K, Koutroubakis IE, Xidakis C, et al. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease. Inflamm Bowel Dis 2006 ; 12 : 100–105. [CrossRef] [PubMed] [Google Scholar]
  33. Otero M, Lago R, Gomez R, et al. Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis 2006 ; 65 : 1198–1201. [CrossRef] [PubMed] [Google Scholar]
  34. Pischon T, Girman CJ, Hotamisligil GS, et al. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004 ; 291 : 1730–1737. [CrossRef] [PubMed] [Google Scholar]
  35. Pang TT, Narendran P. The distribution of adiponectin receptors on human peripheral blood mononuclear cells. Ann NY Acad Sci 2008 ; 1150 : 143–145. [CrossRef] [Google Scholar]
  36. Yokota T, Oritani K, Takahashi I, et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000 ; 96 : 1723–1732. [Google Scholar]
  37. Ouchi N, Kihara S, Arita Y, et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001 ; 103 : 1057–1063. [CrossRef] [PubMed] [Google Scholar]
  38. Kumada M, Kihara S, Ouchi N, et al. Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation 2004 ; 109 : 2046–2049. [CrossRef] [PubMed] [Google Scholar]
  39. Ouedraogo R, Wu X, Xu SQ, et al. Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway. Diabetes 2006 ; 55 : 1840–1846. [CrossRef] [PubMed] [Google Scholar]
  40. Yamaguchi N, Argueta JG, Masuhiro Y, et al. Adiponectin inhibits Toll-like receptor family-induced signaling. FEBS Lett 2005 ; 579 : 6821–6826. [CrossRef] [PubMed] [Google Scholar]
  41. Magalang UJ, Rajappan R, Hunter MG, et al. Adiponectin inhibits superoxide generation by human neutrophils. Antioxid Redox Signal 2006 ; 8 : 2179–2186. [CrossRef] [PubMed] [Google Scholar]
  42. Wulster-Radcliffe MC, Ajuwon KM, Wang J, et al. Adiponectin differentially regulates cytokines in porcine macrophages. Biochem Biophys Res Commun 2004 ; 316 : 924–929. [Google Scholar]
  43. Kappes A, Loffler G. Influences of ionomycin, dibutyryl-cycloAMP and tumour necrosis factor-alpha on intracellular amount and secretion of apM1 in differentiating primary human preadipocytes. Horm Metab Res 2000 ; 32 : 548–554. [CrossRef] [PubMed] [Google Scholar]
  44. Narita K, Murata T, Takahashi T, et al. Plasma levels of adiponectin and tumor necrosis factor-alpha in patients with remitted major depression receiving long-term maintenance antidepressant therapy. Prog Neuropsychopharmacol Biol Psychiatry 2006 ; 30 : 1159–1162. [CrossRef] [PubMed] [Google Scholar]
  45. Anderson PD, Mehta NN, Wolfe ML, et al. Innate immunity modulates adipokines in humans. J Clin Endocrinol Metab 2007 ; 92 : 2272–2279. [CrossRef] [PubMed] [Google Scholar]
  46. Uji Y, Yamamoto H, Maeda K, et al. Adiponectin deficiency promotes the production of inflammatory mediators while severely exacerbating hepatic injury in mice with polymicrobial sepsis. J Surg Res 2010 ; 161 : 301–311. [CrossRef] [PubMed] [Google Scholar]
  47. Hillenbrand A, Knippschild U, Weiss M, et al. Sepsis induced changes of adipokines and cytokines - septic patients compared to morbidly obese patients. BMC Surg 2010 ; 10 : 26. [CrossRef] [PubMed] [Google Scholar]
  48. Smith RS. The macrophage theory of depression. Med Hypotheses 1991 ; 35 : 298–306. [Google Scholar]
  49. Maes M. Major depression and activation of the inflammatory response system. Adv Exp Med Biol 1999 ; 461 : 25–46. [CrossRef] [PubMed] [Google Scholar]
  50. Piccio L, Cantoni C, Henderson JG, et al. Lack of adiponectin leads to increased lymphocyte activation and increased disease severity in a mouse model of multiple sclerosis. Eur J immunol 2013 ; 43 : 2089–2100. [CrossRef] [PubMed] [Google Scholar]
  51. Parkhurst CN, Yang G, Ninan I, et al. Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell 2013 ; 155 : 1596–1609. [CrossRef] [PubMed] [Google Scholar]
  52. Daches S, Kovacs M, George CJ, et al. Childhood adversity predicts reduced physiological flexibility during the processing of negative affect among adolescents with major depression histories. Int J Psychophysiol 2017 ; 121 : 22–28. [CrossRef] [PubMed] [Google Scholar]
  53. Lebe M, Hasenbring MI, Schmieder K, et al. Association of serotonin-1A and -2A receptor promoter polymorphisms with depressive symptoms, functional recovery, and pain in patients 6 months after lumbar disc surgery. Pain 2013 ; 154 : 377–384. [CrossRef] [PubMed] [Google Scholar]
  54. Kishi T, Yoshimura R, Ikuta T, Iwata N. Brain-derived neurotrophic factor and major depressive disorder: evidence from meta-analyses. Front Psychiatry 2017 ; 8 : 308. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.